Intratympanic steroids for meniere's disease or syndrome

In extremely severe cases, treatments that deaden the inner ear such as gentamicin injections or surgery may be considered. This is a last resort for persons who have severe attacks which are disabling. At present, we favor gentamicin for most instances where destructive treatments are being considered. Injections of gentamicin are given through the ear drum, through a small hole or through a small tube. This procedure allows the doctor to treat one side alone, without affecting the other. Typically, about four injections are given over a period of one month. Some authors have reported improvements in 60 to 90 percent of patients with gentamicin (Driscoll et al., 2009; Bodmer, 2007; Boleas-Aguirre, 2007; Chung, 2007), and Chung reported equally effective results with a single injection compared to multiple injections (Chung, 2007). Dizziness may reoccur one year later, requiring another series. Gentamicin injection can also result in hearing loss (Silvertein 2009; Colletti, 2007).

People who experience SSHL should see a physician immediately. Doctors believe that early treatment increases the chances for recovery. Several treatments are used for SSHL, but researchers are not yet certain which is the best for any one cause. The most common therapy for SSHL, especially in cases with an unknown cause, is treatment with steroids. Steroids are used to treat many different disorders and usually work to reduce inflammation, decrease swelling, and help the body fight illness. Another common method that may help some patients is a diet low in salt. Researchers believe that this method aids people with SSHL who also have Ménière's disease, a hearing and balance disorder. A water pill is also frequently prescribed to reduce possible swelling in the inner ear.

A single trial containing 22 patients, with a low risk of bias was included. This trial found that after 24 months, compared with placebo , the use of intratympanic dexamethasone demonstrated a statistically significant improvement in vertigo as defined by a respective improvement in functional level (90% versus 42%), class (82% versus 57%), change in Dizziness Handicap Inventory scores ( versus ) and mean vertigo subjective improvement (90% versus 57%). The treatment regime described by the authors involved daily injections of dexamethasone solution 4 mg/ml for five consecutive days. These results were clinically significant. No complications were reported.

Main Line
Customer Service


News

  • February 14, 2018
    Four Physicians Join DuPage Medical Group
  • January 31, 2018
    DuPage Medical Group Orthopaedic Surgeon Performs Innovative Endoscopic Hip Procedure
  • January 29, 2018
    DuPage Medical Group Welcomes New Chief Operating Officer
DMG Locations Employment Opportunities Media Center FAQ Terms of Use
Privacy Policy
© 2018 by DuPage Medical Group

Intratympanic steroids for meniere's disease or syndrome

intratympanic steroids for meniere's disease or syndrome

Main Line
Customer Service


News

  • February 14, 2018
    Four Physicians Join DuPage Medical Group
  • January 31, 2018
    DuPage Medical Group Orthopaedic Surgeon Performs Innovative Endoscopic Hip Procedure
  • January 29, 2018
    DuPage Medical Group Welcomes New Chief Operating Officer
DMG Locations Employment Opportunities Media Center FAQ Terms of Use
Privacy Policy
© 2018 by DuPage Medical Group

Media:

intratympanic steroids for meniere's disease or syndromeintratympanic steroids for meniere's disease or syndromeintratympanic steroids for meniere's disease or syndromeintratympanic steroids for meniere's disease or syndromeintratympanic steroids for meniere's disease or syndrome

http://buy-steroids.org